Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study
Top Cited Papers
- 1 February 2001
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 357 (9256) , 587-591
- https://doi.org/10.1016/s0140-6736(00)04055-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetilLiver Transplantation and Surgery, 1999
- MYCOPHENOLATE MOFETIL MONOTHERAPY IN STABLE LIVER TRANSPLANT PATIENTS WITH CYCLOSPORINE-INDUCED RENAL IMPAIRMENTTransplantation, 1999
- CHRONIC RENAL FAILURE FOLLOWING LIVER TRANSPLANTATIONTransplantation, 1998
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantationThe Lancet, 1995
- Mycophenolate mofetil: Molecular mechanisms of actionPerspectives in Drug Discovery and Design, 1994
- NEPHROTOXICITY FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1994
- Cyclosporine: mechanisms of action and toxicityCleveland Clinic Journal of Medicine, 1994
- Comparison of Three Immunosuppressive Regimens in Cadaver Renal Transplantation: Long-Term Cyclosporine, Short-Term Cyclosporine Followed by Azathioprine and Prednisolone, and Azathioprine and Prednisolone without CyclosporineNew England Journal of Medicine, 1988
- CYCLOSPORIN CONVERSION VERSUS CONVENTIONAL IMMUNOSUPPRESSION: LONG-TERM FOLLOW-UP AND HISTOLOGICAL EVALUATIONThe Lancet, 1987